BA
The Boeing Company
BA has the edge over GENC overall, supported by stronger fundamentals and stronger modeled upside.
GENC
Gencor Industries, Inc.
GENC trails on the overall score without a compensating advantage in the available component scores.
BA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Under pressure |
BA's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is under pressure.
GENC Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Under pressure | |
| Strong |
GENC's profitability and balance sheet are currently healthy, and its revenue is stable, but its cash flow is under pressure.
BA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $172 | — |
| Cheap | 51x | $496 | +189% |
| Fair | 82x | $790 | +360% |
| Expensive | 91x | $876 | +411% |
Historical ranges are pointers, not guarantees.
BA has the edge over GENC in the historical PE scenario, which offers more potential upside but is not a forecast.
GENC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 14x | $14.16 | -20% |
| Current | 17x | $17.62 | — |
| Fair | 18x | $18.30 | +3.9% |
| Expensive | 39x | $39.17 | +122% |
Historical ranges are pointers, not guarantees.
GENC's PE is in its fair range at 17x.
BA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect BA to return to profit, with revenue growing. However, they disagree widely on these estimates.
GENC Forward outlook
There aren't enough analyst estimates for GENC to show an outlook.
BA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $9.66 | +$23.38 |
| Q2 2026 | $2.78 | +$19.33 |
| Q1 2026 | $2.53 | +$20.49 |
| Q4 2025 | $2.48 | +$20.84 |
| Q3 2025 | -$13.72 | -$0.83 |
| Q2 2025 | -$16.55 | -$10.93 |
| Q1 2025 | -$17.96 | -$14.42 |
| Q4 2024 | -$18.36 | -$14.69 |
BA has the edge over GENC on earnings, with more consistent year-over-year improvement.
GENC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $1.01 | -2.9% |
| Q1 2026 | $0.88 | -7.4% |
| Q4 2025 | $1.04 | +9.5% |
| Q3 2025 | $1.07 | +8.1% |
| Q2 2025 | $1.04 | -5.5% |
| Q1 2025 | $0.95 | -17% |
| Q4 2024 | $0.95 | -10% |
| Q3 2024 | $0.99 | -1% |
GENC earned $1.01 per share over the past year, down 2.9% from the year before.
BA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.2B | +3.9% |
| Q2 2026 | $24.6B | +8% |
| Q1 2026 | $22.2B | +14% |
| Q4 2025 | $23.9B | +57% |
| Q3 2025 | $23.3B | +30% |
| Q2 2025 | $22.7B | +35% |
| Q1 2025 | $19.5B | +18% |
| Q4 2024 | $15.2B | -31% |
BA has the edge over GENC on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.5% | +22 points |
| Q2 2026 | 0.6% | +1.4 points |
| Q1 2026 | 2% | -0.3 points |
| Q4 2025 | 37% | +61 points |
| Q3 2025 | -21% | +12 points |
| Q2 2025 | -0.8% | +5.7 points |
| Q1 2025 | 2.4% | +2.9 points |
| Q4 2024 | -25% | -26 points |
BA's operating margin was 1.5% last quarter, up 22 points from the same quarter a year ago.
GENC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $33.8M | +25% |
| Q1 2026 | $33.8M | -12% |
| Q4 2025 | $23.6M | -25% |
| Q3 2025 | $18.8M | -10% |
| Q2 2025 | $27M | +5.6% |
| Q1 2025 | $38.2M | -6.1% |
| Q4 2024 | $31.4M | +21% |
| Q3 2024 | $20.9M | +0.2% |
GENC's revenue is recovering but still below its 2024 peak: $34M last quarter, up 25% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 17% | +5.5 points |
| Q1 2026 | 13% | -4.4 points |
| Q4 2025 | 13% | -1.6 points |
| Q3 2025 | -1.2% | -7.1 points |
| Q2 2025 | 12% | +3.8 points |
| Q1 2025 | 17% | -0.4 points |
| Q4 2024 | 15% | +1.7 points |
| Q3 2024 | 5.9% | -7 points |
GENC has the edge over BA on profitability, with a higher operating margin.
BA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $464M | +95% |
| Q2 2026 | $631M | +$831M |
| Q1 2026 | -$1.5B | +$836M |
| Q4 2025 | $375M | +$4.5B |
| Q3 2025 | $238M | +$2.2B |
| Q2 2025 | -$200M | +$4.1B |
| Q1 2025 | -$2.3B | +$1.6B |
| Q4 2024 | -$4.1B | -239% |
BA has the edge over GENC on cash generation, producing positive trailing cash flow while its opponent burns cash.
GENC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$17.2M | +$7.2M |
| Q1 2026 | $6.7M | -45% |
| Q4 2025 | $10.1M | -30% |
| Q3 2025 | -$1.3M | +$2M |
| Q2 2025 | -$24.4M | -$23M |
| Q1 2025 | $12.3M | +5.5% |
| Q4 2024 | $14.5M | +848% |
| Q3 2024 | -$3.3M | -130% |
GENC's free cash flow was −$2M over the past year, against −$906,000 the year before.
BA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +2.1M shares |
| 1 year | +4.3% | +32.8M shares |
| 3 years | +31% | +186M shares |
| 5 years | +35% | +204M shares |
| Available history | +40% | +227M shares |
BA has 793M diluted shares, up 4.3% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
GENC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | 0% | -- |
| 3 years | 0% | -- |
| 5 years | -0.6% | -91K shares |
| Available history | -0.3% | -50K shares |
GENC has the edge over BA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2025 | — |
| Q3 2024 | — |
BA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.0x | Elevated |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 6.0x | High |
| Q4 2025 | 6.9x | High |
| Q2 2024 | 361.8x | High |
| Q1 2024 | 36.1x | High |
| Q4 2023 | 36.4x | High |
| Q3 2023 | 96.1x | High |
BA's net debt is about 3.0 years of its operating earnings (EBITDA), down from more than 20 years a year ago.
GENC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -1.6x | Net Cash |
| Q1 2026 | -3.0x | Net Cash |
| Q4 2025 | -2.2x | Net Cash |
| Q3 2025 | -1.4x | Net Cash |
| Q2 2025 | -1.4x | Net Cash |
| Q1 2025 | -2.7x | Net Cash |
| Q4 2024 | -2.0x | Net Cash |
| Q3 2024 | -1.3x | Net Cash |
GENC has the edge over BA on leverage, with a lower net debt burden relative to earnings.
BA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.1 | Neutral |
| Stochastic | 9.6 | Oversold |
BA's weekly RSI is 31 (neutral) and its Stochastic is 10 (oversold).
GENC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.6 | Neutral |
| Stochastic | 48.4 | Neutral |
GENC's weekly RSI is 58 (neutral) and its Stochastic is 48 (neutral).
BA PE vs Industrials Sector
| Metric | BA | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 24x | 26% below |
| PE % | 0 | 58 | 58 pts below |
BA is trading at 18x earnings, a 26% discount to the Industrials sector's median of 24x, though its earnings don't support one.
GENC PE vs Industrials Sector
| Metric | GENC | Sector median | Relative |
|---|---|---|---|
| PE | 17x | 24x | 27% below |
| PE % | 45 | 58 | 13 pts below |
GENC has the edge over BA on valuation relative to its sector.
BA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $184.6 | 7.1% below |
| 20 week MA | $203.8 | 16% below |
| 50 week MA | $215.5 | 20% below |
| 100 week MA | $205.9 | 17% below |
| 200 week MA | $200.6 | 14% below |
BA is in a downtrend: it's below all five of its weekly moving averages, and 14% below its 200-week average.
GENC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $17.5 | 0.7% above |
| 20 week MA | $17.0 | 3.6% above |
| 50 week MA | $15.5 | 14% above |
| 100 week MA | $14.9 | 18% above |
| 200 week MA | $15.8 | 12% above |
GENC has the edge over BA on trend strength, trading above more of its moving averages.
BA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $330.1 | $217.2 | -34% |
| 2021 | $217.2 | $204.2 | -6% |
| 2022 | $204.2 | $189.1 | -7.4% |
| 2023 | $189.1 | $260.7 | +38% |
| 2024 | $260.7 | $180.7 | -31% |
| 2025 | $180.7 | $216.4 | +20% |
| 2026 YTD | $216.4 | $171.6 | -21% |
BA has finished lower in four of the last six years. It's down 21% so far in 2026.
GENC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $11.8 | $11.8 | 0% |
| 2021 | $11.8 | $11.6 | -1.6% |
| 2022 | $11.6 | $10.4 | -10% |
| 2023 | $10.4 | $16.1 | +55% |
| 2024 | $16.1 | $17.4 | +7.8% |
| 2025 | $17.4 | $12.6 | -28% |
| 2026 YTD | $12.6 | $17.6 | +40% |
GENC has the edge over BA on returns for 2026, with the stronger performance.